Express & Expedited Shipping Service
USD $688.36
IndiaGiotrif, also known by its generic name afatinib, is an oral medication used primarily in the treatment of specific types of non-small cell lung cancer (NSCLC). It is classified as a tyrosine kinase inhibitor (TKI), which targets and inhibits the activity of certain proteins responsible for the growth and spread of cancer cells.
Giotrif works by blocking the action of epidermal growth factor receptor (EGFR) proteins on the surface of cancer cells. By inhibiting these proteins, Giotrif prevents the cancer cells from receiving signals that promote their growth and division, thereby slowing down or stopping the progression of the cancer.
Giotrif is specifically designed for patients diagnosed with non-small cell lung cancer that exhibits mutations in the EGFR gene. It is particularly effective in treating patients whose cancer has progressed despite prior chemotherapy treatments.
Giotrif is administered orally in the form of tablets. It is typically taken once daily on an empty stomach, at least one hour before or three hours after eating. Patients should follow their healthcare provider's instructions regarding dosage and duration of treatment.
Common side effects of Giotrif may include diarrhea, skin rash, mouth sores, and dry skin. Some patients may also experience nausea, vomiting, and decreased appetite. It is important for patients to report any severe or persistent side effects to their healthcare provider.
Before starting Giotrif, patients should inform their healthcare provider of any other medications they are taking and any pre-existing health conditions. Regular monitoring and follow-up appointments are essential to ensure the treatment's effectiveness and manage any potential side effects.
Giotrif is often used as a monotherapy, but depending on the patient's condition and response to treatment, healthcare providers may consider combining it with other therapeutic approaches. It is crucial to have a detailed discussion with a healthcare provider to determine the most suitable treatment plan.
Health Guides
Nov 02, 2026
ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 27, 2026
Benign prostatic hyperplasia (BPH) is a noncancerous enlarged prostate. Alpha blockers ease urinary symptoms by relaxing muscle around the outlet, often within days to weeks. 5-alpha-reductase inhibitors (5-ARIs) shrink the prostate gradually and can reduce the risks of urinary retention and surgery
Oct 25, 2026
Oral cancer medication safety depends on following the prescribed schedule, protecting household members from exposure, and reporting symptoms promptly. Tablets should stay intact, caregivers should use disposable gloves, and food or medicine changes need an oncology pharmacist's review. At-home o
Oct 13, 2026
A COPD diagnosis often leads to several prescriptions, each with a different job. A rescue inhaler eases sudden breathing symptoms. Long-acting bronchodilators are taken daily to control breathlessness and reduce exacerbations. Inhaled corticosteroids may be prescribed for people with recurrent fla
Oct 07, 2026
A medicine that prevents a stroke can also increase surgical bleeding, while stopping it can raise the risk of a clot. Preparing medications before surgery requires a written, individualized plan, not a blanket instruction to stop daily prescriptions. The short answer: Give the surgical team a comp
Oct 04, 2026
Grapefruit can change how much medication reaches the bloodstream, even when the prescribed dose stays the same. Grapefruit drug interactions affect certain cholesterol, blood pressure, transplant, cancer, and allergy medicines, but the risk depends on the exact medicine. For some drugs, exposure ri
Sep 21, 2026
Multiple daily doses turn an ordinary routine into a safety task. A missed tablet, an extra dose, or an over-the-counter product added without review can cause harm, especially for people managing heart disease, diabetes, transplants, epilepsy, or cancer treatment with prescription medications. A sa
Sep 18, 2026
The first dose is when a prescription label deserves careful attention. A first-time user should verify the patient, medication identity, strength, dosage form, route, timing, warnings, and storage directions before taking it. Before taking prescription medicine, use the medication label to confirm
Sep 17, 2026
A hospital stay can leave patients with two conflicting medication lists, unfamiliar pills, and little time to sort out the differences. That confusion can threaten patient safety, especially for people taking insulin, anticoagulants, transplant medicines, oral cancer therapy, or several long-term p
